Mice lacking circadian clock components display different mood-related behaviors and do not respond uniformly to chronic lithium treatment

Chronobiology International
Anna SchnellUrs Albrecht

Abstract

Genomic studies suggest an association of circadian clock genes with bipolar disorder (BD) and lithium response in humans. Therefore, we tested mice mutant in various clock genes before and after lithium treatment in the forced swim test (FST), a rodent behavioral test used for evaluation of depressive-like states. We find that expression of circadian clock components, including Per2, Cry1 and Rev-erbα, is affected by lithium treatment, and thus, these clock components may contribute to the beneficial effects of lithium therapy. In particular, we observed that Cry1 is important at specific times of the day to transmit lithium-mediated effects. Interestingly, the pathways involving Per2 and Cry1, which regulate the behavior in the FST and the response to lithium, are distinct as evidenced by the phosphorylation of GSK3β after lithium treatment and the modulation of dopamine levels in the striatum. Furthermore, we observed the co-existence of depressive and mania-like symptoms in Cry1 knock-out mice, which resembles the so-called mixed state seen in BD patients. Taken together our results strengthen the concept that a defective circadian timing system may impact directly or indirectly on mood-related behaviors.

References

Jul 15, 1990·Biological Psychiatry·D K Welsh, M C Moore-Ede
Jan 1, 1982·Neuropsychobiology·M S KafkaT A Wehr
Apr 21, 1980·Life Sciences·D F Kripke, V G Wyborney
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P S Klein, D A Melton
Jul 1, 1998·Biological Psychiatry·F M BenesM S Todtenkopf
Aug 10, 1999·Nature·T S Zheng, R A Flavell
Jul 6, 2000·Nature·S S MagaviJ D Macklis
Sep 15, 2000·Journal of Neurochemistry·G ChenH K Manji
Apr 17, 2001·Journal of Biological Rhythms·U AlbrechtC C Lee
Jan 1, 2003·Seminars in Cancer Biology·Richard C GregoryAlan D D'Andrea
Nov 4, 2004·Journal of Biological Rhythms·Kamiel SpoelstraSerge Daan
May 19, 2005·Bipolar Disorders·Stephanie KrügerPeter Bräunig
Jun 1, 2005·Neuroscience and Biobehavioral Reviews·Cai Song, Brian E Leonard
Mar 11, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Caroline M NievergeltJohn R Kelsoe
Mar 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kole RoybalColleen A McClung
Apr 26, 2007·Annals of Medicine·Timo PartonenGunter Schumann
Jan 30, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jiajun ShiChunyu Liu
Jun 3, 2008·Current Biology : CB·Eddy A Van der ZeeMenno P Gerkema
Sep 20, 2008·Nature Reviews. Genetics·Joseph S TakahashiErin L McDearmon
Jan 27, 2009·Journal of Circadian Rhythms·Daniel F KripkeJohn R Kelsoe
Mar 31, 2009·BMC Neuroscience·Laurence BorgsBrigitte Malgrange
Nov 17, 2009·BMC Psychiatry·Casey L McGrathMing T Tsuang
Dec 1, 2009·Cell Cycle·Mary L SpenglerMarina P Antoch
Dec 17, 2009·Annual Review of Clinical Psychology·Jennifer Y F Lau, Thalia C Eley
Jan 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Virginia SoriaMikel Urretavizcaya
Feb 13, 2010·Annual Review of Physiology·David K WelshSteve A Kay
Apr 7, 2010·Annals of Medicine·Daniela D PollakFrancisco J Monje
Sep 30, 2010·Nature Neuroscience·Eric J Nestler, Steven E Hyman
Mar 5, 2011·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Nciri RiadhAbdelfattah Elfeki
Mar 15, 2011·The European Journal of Neuroscience·Benjamin A Samuels, René Hen
Sep 8, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H U WittchenH-C Steinhausen

❮ Previous
Next ❯

Citations

Aug 16, 2016·Sleep Medicine Reviews·Matias C A MeloVeralice M S de Bruin
Nov 2, 2016·Psychiatry and Clinical Neurosciences·Ekaterina SigitovaJiří Raboch
Jan 18, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Pierre A GeoffroyCynthia Marie-Claire
Dec 14, 2017·Frontiers in Neurology·Adriano Barreto NogueiraManoel Jacobsen Teixeira
Dec 27, 2018·Antioxidants & Redox Signaling·Yeni KimRenata Santos
May 11, 2019·Cell and Tissue Research·Jorge Mendoza, Guillaume Vanotti
Dec 13, 2017·Neural Plasticity·Chelsea A Vadnie, Colleen A McClung
Feb 23, 2017·Frontiers in Neurology·Urs Albrecht
Dec 14, 2017·International Journal of Molecular Sciences·Eunsoo Won, Yong-Ku Kim
Feb 6, 2019·Frontiers in Molecular Neuroscience·Hyo Kyeong ChaGi Hoon Son
Nov 30, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael J McCarthyJohn R Kelsoe
Mar 7, 2017·Frontiers in Cellular Neuroscience·Yeni KimMaria C Marchetto
Apr 4, 2017·Neural Plasticity·Malgorzata Jasinska, Elzbieta Pyza
Dec 22, 2019·Journal of Molecular Biology·Urs Albrecht
May 25, 2021·Frontiers in Psychiatry·Tao YanLinglin Yang
Jul 9, 2021·PLoS Genetics·Iwona OlejniczakUrs Albrecht

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.